Quantifying additional COVID-19 symptoms will save lives.
Ontology highlight
ABSTRACT:
SUBMITTER: Menni C
PROVIDER: S-EPMC7272184 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
Publications
Quantifying additional COVID-19 symptoms will save lives.
Menni Cristina C Sudre Carole H CH Steves Claire J CJ Ourselin Sebastien S Spector Tim D TD
Lancet (London, England) 20200604 10241
Similar Datasets
Project description:ObjectivesThe aim of the study was to assess the impact of social distancing interventions in Greece and to examine what would have happened if those interventions had not been implemented.Study designA dynamic, discrete time, stochastic individual-based model was developed to simulate coronavirus disease 2019 (COVID-19) transmission.MethodsThe model was fitted to the observed trends in COVID-19 deaths and intensive care unit (ICU) bed use in Greece.ResultsIf Greece had not implemented social distancing interventions, the healthcare system would have been overwhelmed between March 30 and April 4. The combined social distancing interventions and increase in ICU beds averted 4360 (95% credible interval: 3050, 5700) deaths and prevented the healthcare system from becoming overwhelmed.ConclusionsThe quick and accurate interventions of the Greek government limited the burden of the COVID-19 outbreak.
| S-EPMC7447221 | biostudies-literature
Project description:Chemistry and biochemistry instructors
| S-EPMC9999942 | biostudies-literature
Project description:Global vaccination effort and better understanding of treatment strategies provided a ray of hope for improvement in COVID-19 pandemic, however, in many countries, the disease continues to collect its death toll. The major pathogenic mechanism behind severe cases associated with high mortality is the burst of pro-inflammatory cytokines TNF, IL-6, IFNγ and others, resulting in multiple organ failure. Although the exact contribution of each cytokine is not clear, we provide an evidence that the central mediator of cytokine storm and its devastating consequences may be TNF. This cytokine is known to be involved in activated blood clotting, lung damage, insulin resistance, heart failure, and other conditions. A number of currently available pharmaceutical agents such as monoclonal antibodies and soluble TNF receptors can effectively prevent TNF from binding to its receptor(s). Other drugs are known to block NFkB, the major signal transducer molecule used in TNF signaling, or to block kinases involved in downstream activation cascades. Some of these medicines have already been selected for clinical trials, but more work is needed. A simple, rapid, and inexpensive method of directly monitoring TNF levels may be a valuable tool for a timely selection of COVID-19 patients for anti-TNF therapy.
| S-EPMC8787182 | biostudies-literature
Project description:This paper studies whether containing COVID-19 pandemic by stringent strategies deteriorates or saves economic growth. Since there are country-specific factors that could affect both economic growth and deaths due to COVID-19, we first start with a cross-country analysis on identifying risk and protective factors on the COVID-19 deaths using large across-country variation. Using data on 100 countries from 3 January to 27 November 2020 and taking into account the possibility of underreporting, we find that for deaths per million population, GDP per capita, population density, and income inequality are the three most important risk factors; government effectiveness, temperature, and hospital beds are the three most important protective factors. Second, inspired by the stochastic frontier literature, we construct a measure of pandemic containment effectiveness (PCE) after controlling for country-specific factors and rank countries by their PCE scores for deaths. Finally, by linking the PCE score with GDP growth data in Quarters 2 and 3 of 2020, we find that PCE is positively associated with economic growth in major economies. Countries with average PCE scores, such as Malaysia, would gain more GDP growth by 3.47 percentage points if they could improve their PCE scores for deaths to South Korea's level in Q2 of 2020. Therefore, there is not a trade-off between lives and livelihood facing by governments. Instead, to save economy, it is important to contain the pandemic first. Our conclusion is also mainly valid for infections due to COVID-19.
| S-EPMC8907024 | biostudies-literature
Project description:We quantify the effect of statewide mask mandates in the United States in 2020. Our regression discontinuity design exploits county-level variation in COVID-19 outcomes across the border between states with and without mandates. State mask mandates reduced new weekly COVID-19 cases, hospital admissions, and deaths by 55, 11, and 0.7 per 100,000 inhabitants on average. The effect depends on political leaning with larger effects in Democratic-leaning counties. Our results imply that statewide mandates saved 87,000 lives through December 19, 2020, while a nationwide mandate could have saved 57,000 additional lives. This suggests that mask mandates can help counter pandemics, particularly if widely accepted.
| S-EPMC9968482 | biostudies-literature
Project description:Health insurance characteristics shift at age 65 as most people become eligible for Medicare. We measure the impacts of these changes on patients who are admitted to hospitals through emergency departments for conditions with similar admission rates on weekdays and weekends. The age profiles of admissions and comorbidities for these patients are smooth at age 65, suggesting that the severity of illness is similar on either side of the Medicare threshold. In contrast, the number of procedures performed in hospitals and total list charges exhibit small but statistically significant discontinuities, implying that patients over 65 receive more services. We estimate a nearly 1-percentage-point drop in 7-day mortality for patients at age 65, equivalent to a 20% reduction in deaths for this severely ill patient group. The mortality gap persists for at least 9 months after admission.
| S-EPMC2777733 | biostudies-literature
Project description:Voluminous vaccine campaigns have been used globally, since the COVID-19 pandemic has brought devastating mortality and destructively unprecedented consequences to different aspects of economies. This study aimed to identify how the numbers of new deaths and new cases per million changed after half of the population had been vaccinated. This paper used actual pandemic consequence variables (death and infected rates) together with vaccination uptake rates from 127 countries to shed new light on the efficacy of COVID-19 vaccines. The 50% uptake rate was chosen as the threshold to estimate the real benefits of vaccination campaigns for reducing COVID-19 infection and death cases using the difference-in-differences (DiD) imputation estimator. In addition, a number of control variables, such as government interventions and people's mobility patterns during the pandemic, were also included in the study. The number of new deaths per million significantly decreased after half of the population was vaccinated, but the number of new cases did not change significantly. We found that the effects were more pronounced in Europe and North America than in other continents. Our results remain robust after using other proxies and testing the sensitivity of the vaccinated proportion. We show the causal evidence of significantly lower death rates in countries where half of the population is vaccinated globally. This paper expresses the importance of vaccine campaigns in saving human lives during the COVID-19 pandemic, and its results can be used to communicate the benefits of vaccines and to fight vaccine hesitancy.
| S-EPMC9152627 | biostudies-literature
Project description:A wide variety of animals become completely immobile after initial contact with a potential predator. This behaviour is considered to be a last-ditch escape strategy. Here, we test the hypothesis that such immobility should have an extremely unpredictable duration. We find that it spans more than three orders of magnitude in antlion larvae. We also analyse the second period of immobility that follows the first bout of immobility, and consider the distributions of both first and second immobility periods within the context of the intermittence that characterizes the movement of most organisms. Both immobility durations were fitted best by exponential distributions. Therefore, both were characterized by high variability and hence, unpredictability. The immobility half-life, its mean duration and standard deviation were greater for the first than the second immobility. Furthermore, individual consistency was weak or absent in repeated measures of the first immobility and between the first and second immobilities. Our quantitative approach can be replicated across taxa and would help link an understanding of immobility after an initial predator contact in both vertebrates and invertebrates. To facilitate this, we contend that the terminology should be simplified, and we advocate the use of the term post-contact immobility (PCI).
| S-EPMC7423462 | biostudies-literature
Project description:The current 2019 novel coronavirus disease (COVID-19), an emerging infectious disease, is undoubtedly the most challenging pandemic in the 21st century. A total of 92,977,768 confirmed cases of COVID-19 and 1,991,289 deaths were reported globally up to January 14, 2021. COVID-19 also affects people's mental health and quality of life. At present, there is no effective therapeutic strategy for the management of this disease. Therefore, in the absence of a specific vaccine or curative treatment, it is an urgent need to identify safe, effective and globally available drugs for reducing COVID-19 morbidity and fatalities. In this review, we focus on selective serotonin reuptake inhibitors (SSRIs: a class of antidepressant drugs with widespread availability and an optimal tolerability profile) that can potentially be repurposed for COVID-19 and are currently being tested in clinical trials. We also summarize the existing literature on what is known about the link between serotonin (5-HT) and the immune system. From the evidence reviewed here, we propose fluoxetine as an adjuvant therapeutic agent for COVID-19 based on its known immunomodulatory, anti-inflammatory and antiviral properties. Fluoxetine may potentially reduce pro-inflammatory chemokine/cytokines levels (such as CCL-2, IL-6, and TNF-α) in COVID-19 patients. Furthermore, fluoxetine may help to attenuate neurological complications of COVID-19.
| S-EPMC7973060 | biostudies-literature
Project description: Not available
| S-EPMC7152912 | biostudies-literature